 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
News Briefs Ethiopia Ready to Start Nevirapine Trials for AIDS TreatmentNovember 20, 2002 A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! Ethiopia's government is ready to begin testing nevirapine, used to prevent mother-to-child HIV transmission, the daily Addis Zemen reported. Health officials said initial trials of the drug would take place in five cities, including the capital Addis Ababa, following work to boost hospital capacity and ensure patient follow-up. Nevirapine could cut mother-to-child HIV transmission by 50 percent, according to HIV/AIDS experts at the Faculty of Medicine at the University of Addis Ababa. Between 6.4 percent and 7.3 percent of Ethiopia's adult population are estimated to be HIV-positive. Almost a million children in Ethiopia are AIDS orphans. Nevirapine is being provided free by a large pharmaceutical company, which the government daily did not name. The international drug company Boehringer-Ingelheim recently proposed to provide free nevirapine to developing countries. Back to other CDC news for November 20, 2002 Agence France Presse 11.18.02 A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
|
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
